首页> 外国专利> Compound with a structure of formula (I), a pharmacologically acceptable salt thereof or an optical isomer thereof,The pharmaceutical composition and the use of the compound of formula (I) for the treatment and prevention of Mycobacterium tuberculosis or other microbial infections

Compound with a structure of formula (I), a pharmacologically acceptable salt thereof or an optical isomer thereof,The pharmaceutical composition and the use of the compound of formula (I) for the treatment and prevention of Mycobacterium tuberculosis or other microbial infections

机译:具有式(I)结构的化合物,其药理学上可接受的盐或其旋光异构体,所述药物组合物和所述式(I)化合物在治疗和预防结核分枝杆菌或其他微生物感染中的用途

摘要

The present invention relates to a derivative of nitroimidazol replaced, which is mainly used for treating diseases caused by Mycobacterium infections.As for mycobacteria tuberculosis, especially being suitable for diseases caused by tuberculosis by Mycobacterium tuberculosis resistant.
机译:本发明涉及一种取代的硝基咪唑的衍生物,其主要用于治疗由分枝杆菌感染引起的疾病。至于结核分枝杆菌,特别适用于由耐结核分枝杆菌引起的结核病。

著录项

  • 公开/公告号BR112017015744A2

    专利类型

  • 公开/公告日2018-03-13

    原文格式PDF

  • 申请/专利权人 MEDSHINE DISCOVERY INC.;

    申请/专利号BR20171115744

  • 申请日2016-01-28

  • 分类号C07D519;A61K31/437;A61K31/4375;A61K31/4545;A61K31/4985;A61K31/519;A61K31/5377;A61P31/06;

  • 国家 BR

  • 入库时间 2022-08-21 12:53:43

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号